CIPROCAM EAR DROP HIPRO HC EAR TIXIM TIXIM TIXIM CINFLOX EXETOP EXETOP STACIPROCIN STACIPROCIN EROZIANT ELOX ELOX GLIF GLIF GLIF ZUROXIN ZUROXIN MOROFLOX MOROFLOX C-OXIME C-OXIME C-OXIME TYRACIP

Dose: 0.143 to 0.285 mg/kg
Single Dose: 0.21 (0.214)
Frequency: 24 hourly
Route: PO
Instructions: Initial

Debrisoquine (Sulphate) also known as Isocaramidine Sulphate. . It is of Synthetic origin and belongs to Isoquinoline. It belongs to Antihypertensive Agents pharmacological group.The Molecular Weight of Debrisoquine (Sulphate) is 448.50. Its pKa is 11.9.

Debrisoquine (Sulphate) is contraindicated in conditions like Phaeochromocytoma,Renal failure.

Debrisoquine (Sulphate) produces potentially life-threatening effects which include Blood pressure reduction. which are responsible for the discontinuation of Debrisoquine (Sulphate) therapy.The signs and symptoms that are produced after the acute overdosage of Debrisoquine (Sulphate) include Orthostatic hypotension.The symptomatic adverse reactions produced by Debrisoquine (Sulphate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Syncope, Failure of ejaculation.

Debrisoquine (Sulphate) is primarily indicated in conditions like Hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Amoebic dysentry, Granulomatous disease, Skin lesions.

Debrisoquine (Sulphate) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAdrenalineAlcoholAmitriptyline (HCl)Chlorpromazine (HCl)Desipramine (HCl)Dothiepin (HCl)Doxepin (HCl)Imipramine (HCl)Lofepramine (HCl)Theoretical potential for LOFEPRAMINE reducing the HYPOTENSIVE effect of DEBRISOQUINE. Noradrenaline (Acid Tartrate)Phenylpropanolamine (HCl)Trimipramine (Maleate) These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, patients suffering from Kidney dysfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store in a well closed container. Protect from Sunlight.

Take this medication as directed by physician. Take no more of the medication than the amount prescribed. Take with food to minimize possible gastrointestinal irritation.